US2013178368A1PendingUtilityA1
In vitro evolution in microfluidic systems
Est. expiryOct 8, 2024(expired)· nominal 20-yr term from priority
B01L 2200/0673C12Q 1/6874B01L 3/502784B01J 2219/00466B01L 2300/0654B01L 3/502776B01J 2219/00722B01J 2219/00468B01J 2219/00576B01L 2400/0487G01N 15/1459B01J 2219/005C12N 15/1058B01J 2219/00545B01L 2400/0415G01N 15/1484B01L 2300/0867B01L 2300/0816C12N 15/1075B01J 19/0046B01L 3/502753B01L 2200/0636B01L 3/502746B01L 2300/0864B01J 2219/00657C12P 21/00B01J 2219/0052B01F 33/3031B01F 25/4338B01F 23/41B01F 25/4331B01F 33/3021B01F 33/3011B01F 25/433G01N 15/149
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.
Claims
exact text as granted — not AI-modified1 - 107 . (canceled)
108 . A method for preparing an entity for analysis, the method comprising:
obtaining a first fluid comprising a plurality of entities; and forming droplets of the first fluid, each comprising multiple copies of a subset of said plurality, in a channel that contains droplets of a second fluid flowing in a third fluid, wherein the first, second, and third fluids are immiscible with each other.
109 . The method according to claim 108 , wherein the first fluid is an aqueous fluid and the second and third fluids are different oils.
110 . The method according to claim 109 , wherein the third fluid is a fluorinated or perfluorinated oil.
111 . The method according to claim 108 , wherein the droplets of the first fluid are separated by droplets of the second fluid.
112 . The method according to claim 108 , wherein the entities are nucleic acids, proteins, or cells.
113 . The method according to claim 108 , wherein the entities are labeled.
114 . The method of claim 113 , wherein the entities are optically labeled.
115 . The method of claim 114 , wherein the entities are fluorescently labeled antibodies.
116 . The method of claim 113 , wherein the entities are chemically labeled antibodies.
117 . The method of claim 108 , wherein the first and second droplets are monodisperse with respect to each other.
118 . The method according to claim 108 , wherein the entities are attached to microbeads.
119 . The method according to claim 108 , wherein at least one of the first droplets includes only a single type of entity, present in multiple copies.
120 . The method according to claim 108 , further comprising conducting a reaction in the first droplets.
121 . The method according to claim 120 , further comprising detecting a reaction product in the first droplets.
122 . The method according to claim 121 , wherein said detecting step comprises optically detecting.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.